<ѻýҕl>No Laughing Matter: Nitrous Oxide for Transrectal Prostate Biopsyѻýҕl> No effect on anxiety but significantly less patient-rated pain Jan 12, 2024
<ѻýҕl>Trump-Era Conscience Rule Rescinded; Lloyd Austin's Cancer; Sinead O'Connor's Deathѻýҕl> Health news and commentary from around the Web gathered by ѻýҕl staff Jan 10, 2024
<ѻýҕl>More Evidence Linking ADT for Prostate Cancer to Adverse Neurocognitive Effectsѻýҕl> Meta-analysis shows increased risk of dementia, Parkinson's, depression Jan 09, 2024
<ѻýҕl>Cancer Patients Face Frightening Delays in Treatment Approvalsѻýҕl> "For them to take weeks -- up to months -- to provide an authorization is ridiculous" Dec 30, 2023
<ѻýҕl>FDA Warns Amazon Over Supplements Containing Erectile Dysfunction Drugsѻýҕl> Agency bought and tested products that were found to contain tadalafil and sildenafil Dec 29, 2023
<ѻýҕl>Testosterone for Hypogonadism Cleared So Far of Prostate Cancer Riskѻýҕl> No excess high-grade or overall prostate cancer risk in TRAVERSE with 33 months of follow-up Dec 27, 2023
<ѻýҕl>Shorter Antibiotic Course Noninferior for UTI Recurrence in Kidsѻýҕl> 5-day course should minimize adverse effects, reduce healthcare costs, and improve adherence Dec 26, 2023
<ѻýҕl>You Think the TREE Is Crooked: Penile Fractures Up at Christmasѻýҕl> Painful sex-related injuries jump as stockings are stuffed, German study finds Dec 22, 2023
<ѻýҕl>Iodine Linked With Men's Testosterone Levelsѻýҕl> Results suggest "excess iodine is not harmless," said researcher Dec 21, 2023
<ѻýҕl>Sharp Uptick in Gender-Affirming Hormone Therapy Visits After ACA's Passageѻýҕl> Large database analysis shows room for more HIV testing, prevention Dec 18, 2023
<ѻýҕl>FDA Approves New First-Line Standard of Care in Bladder Cancerѻýҕl> Enfortumab vedotin plus pembrolizumab doubled survival as compared with chemotherapy Dec 15, 2023
<ѻýҕl>FDA Approves Belzutifan for Advanced Renal Cell Carcinomaѻýҕl> HIF-2 inhibitor indicated for patients who progress after immunotherapy and anti-VEGF Dec 15, 2023
<ѻýҕl>TULSA Effective in Controlling Prostate Cancer Long-Termѻýҕl> At 5 years, median PSA was reduced by 90% Dec 05, 2023
<ѻýҕl>'Watch and Wait' With Small Renal Masses: When and How Should Docs Intervene?ѻýҕl> Phillip Pierorazio, MD, outlines how to be a good steward of active surveillance Dec 04, 2023
<ѻýҕl>Oncolytic Virus Shows High Response Rates in BCG-Unresponsive Bladder Cancerѻýҕl> Results from interim analysis suggest "potential to disrupt the NMIBC treatment landscape" Dec 01, 2023
<ѻýҕl>Noninvasive Therapy Shows Efficacy in Non-Muscle-Invasive Bladder Cancerѻýҕl> Investigational intravesical solution led to complete response rate of 79% Nov 30, 2023
<ѻýҕl>Diagnostic Imaging Not Yet Enough for Biopsy-Free Radical Prostatectomyѻýҕl> Study validates concerns about benign prostatic hyperplasia-related PSMA-PET false positives Nov 27, 2023
<ѻýҕl>'We're Not There Yet': CAR T-Cell Therapy for Renal Cell Carcinomaѻýҕl> Potential standard of care after current therapies, but key obstacles remain in the way Nov 15, 2023
<ѻýҕl>Targeting New Pathways to Improve Outcomes in Renal Cell Carcinomaѻýҕl> Building on recent success requires intervention at multiple steps in the cancer immunity cycle Nov 14, 2023
<ѻýҕl>Tyrosine Kinase Inhibitor Active in Heavily Treated Renal Cell Carcinomaѻýҕl> Responses to "special drug" zanzalintinib in cabozantinib-exposed and unexposed patients Nov 11, 2023
<ѻýҕl>Moving Beyond the 'Angelina Jolie Effect' to Address Cancer Disparitiesѻýҕl> A "local heroes effect" can better reach communities of color Nov 09, 2023
<ѻýҕl>Transitioning Cancer Survivors Away From Oncologic Careѻýҕl> It's time for a new model of care Nov 03, 2023
<ѻýҕl>Reduced-Dose Schedule of Cabazitaxel Viable for Seniors With mCRPCѻýҕl> Grade 3 or higher neutropenia, neutropenic complications reduced by 12-fold Nov 01, 2023
<ѻýҕl>Radionuclide Therapy Tops AR-Pathway Inhibitor Switch for mCRPCѻýҕl> Time to radiographic progression doubled with 177Lu-PSMA-617 Oct 25, 2023
<ѻýҕl>Randomized Trial Backs HIF-2a Inhibition in Advanced RCCѻýҕl> After immunotherapy-TKI failure, belzutifan produces better outcomes versus everolimus Oct 24, 2023
<ѻýҕl>Landmark Trial Produces New First-Line Standard for Advanced Bladder Cancerѻýҕl> Enfortumab vedotin-pembrolizumab doubles OS, PFS versus chemotherapy Oct 22, 2023
<ѻýҕl>Carbohydrates and Long-Term Weight Change; Value of Cardiac Transfersѻýҕl> Also in TTHealthWatch: reducing infections in joint replacement Oct 21, 2023 podcast
<ѻýҕl>Should Older Prostate Cancer Patients Jump Off the Active Surveillance Train?ѻýҕl> It's time for clear guidelines Oct 18, 2023
<ѻýҕl>Single Dose of Antibiotic Cured Early Syphilis, Even in Those With HIVѻýҕl> One dose proved noninferior to triple-dose regimen in randomized trial Oct 16, 2023
<ѻýҕl>Bladder-Sparing Neoadjuvant Protocol Gets High Marks for MIBCѻýҕl> Complete clinical response predicted favorable outcomes for up to 2 years Oct 06, 2023
<ѻýҕl>SBRT Noninferior to Conventional RT for Intermediate-Risk Prostate Cancerѻýҕl> Treatment over 1 to 2 weeks achieves similar outcomes to therapy given for as long as 7.5 weeks Oct 03, 2023
<ѻýҕl>FDA OKs Another Injectable for Rare Kidney Disorderѻýҕl> Nedosiran approved for patients ages 9 years and older with primary hyperoxaluria type 1 Oct 02, 2023
<ѻýҕl>SBRT Added to Standard Tx Boosts Outcomes in Oligometastatic Prostate Cancerѻýҕl> Combination improved biochemical response and PFS compared with systemic treatment alone Sep 27, 2023
<ѻýҕl>Global Incidence of Early-Onset Cancer Has Surged Since 1990ѻýҕl> Early-onset breast cancer has highest incidence and mortality rates Sep 06, 2023
<ѻýҕl>Prostate Cancer Is Not Just an 'Old Man's Disease'ѻýҕl> Spreading this message can save lives Sep 02, 2023
<ѻýҕl>Testosterone Loss in Older Men: Factors Beyond Age in the Mixѻýҕl> Several lifestyle, health factors associated with declining levels Aug 28, 2023
<ѻýҕl>Does Cancer Screening Actually Extend Lives?ѻýҕl> A series of articles look at whether the benefits for the few warrant the harms for the many Aug 28, 2023
<ѻýҕl>Gender Affirming Surgeries Nearly Tripled in the U.S. From 2016 to 2019ѻýҕl> Breast and chest procedures most common, followed by genital reconstruction Aug 25, 2023
<ѻýҕl>FDA Grants De Novo Request for Neuromodulatory System for Urge Incontinenceѻýҕl> Three-fourths of patients had 50% reduction in incontinence at 6 months, 82% at 12 months Aug 18, 2023
<ѻýҕl>Older Surgical Procedure for Pelvic Prolapse Repair Prevails in Randomized Trialѻýҕl> Another study showed vaginal estrogen during prolapse repair did not affect surgical outcomes Aug 17, 2023